Skip to main content

SurModics Buys CodeLink Activated Slide Business from GE Healthcare

NEW YORK (GenomeWeb News) – SurModics said yesterday that it has acquired the CodeLink Activated Slide microarray business from GE Healthcare for an undisclosed sum.
 
The slide business was the one piece of the CodeLink business that GE retained when it sold the CodeLink products and assets to Applied Microarrays in April 2007.
 
Eden Prairie, Minn.-based SurModics makes the PhotoLink technology that is used to create a three-dimensional matrix that enables the attachment of biomolecules, including DNA, RNA, and proteins, to form microarrays. Its technology has been used to create CodeLink Activated Slides for several years.
 
“Selling these products directly will allow us to get closer to our customers and offer a broader range of products, which is consistent with our strategic growth initiative of diversification,” said Bruce Barclay, president and CEO of SurModics, in a statement.
 
The firms did not disclose annual revenues for the Activated Slides business.
The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.